Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mark Kowalski, Ian Mortimer, Jeffrey Jonas

Premium

Tekmira Pharmaceuticals has appointed Mark Kowalski as its chief medical officer.

Before joining Tekmira, he was chief medical officer of YM BioSciences. He joined Gilead Sciences following its acquisition of YM.


Tekmira also disclosed that its CFO Ian Mortimer will leave the company Oct. 15. He has been with Tekmira for five years.

The search for a new CFO is underway.


Sage Therapeutics has named Jeffrey Jonas as its new CEO.

Jonas previously served as executive vice president of Isis Pharmaceuticals.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.